InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Galluppi Stefan, Chief Technology Officer. Officer active across 2 companies, notably LifeMD, Inc.. Aggregated, 6 filings have been recorded. Total volume traded: €82k. The latest transaction was filed on 17 November 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€423100 shares@ €4.2310.0003% mcap4.8% of flow
Common Stock, par value $0.01
SEC:0001362118-21-000043·
Ideal exit: 14 Aug 2022 (T+270)
€423100 shares@ €4.2310.0003% mcap0.8% of flow
Common Stock, par value $0.01
SEC:0001362118-21-000043:0·
Ideal exit: 14 Aug 2022 (T+270)
€8,3392,097 shares@ €3.97670.0051% mcap95.2% of flow
Common Stock, par value $0.01
SEC:0001362118-21-000042·
Ideal exit: 12 Aug 2022 (T+270)
€8,3392,097 shares@ €3.97670.0051% mcap16.7% of flow
Common Stock, par value $0.01
SEC:0001362118-21-000042:0·
Ideal exit: 12 Aug 2022 (T+270)
€32,4323,796 shares@ €8.5436100.0% of flow
Common Stock, par value $0.01
SEC:0001362118-21-000014·
Ideal exit: 13 Feb 2022 (T+270)
€32,4323,796 shares@ €8.54360.020% mcap64.9% of flow
Common Stock, par value $0.01
SEC:0001362118-21-000014:0·
Ideal exit: 13 Feb 2022 (T+270)
6 of 6 declarations
About Galluppi Stefan
Stefan Galluppi is the Chief Technology Officer of LifeMD, Inc. He oversees technological development and innovation within the company. His role is essential in ensuring that the organization remains at the forefront of technological advancements.
